LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common stock
13,600
$39.06
$531,148
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common stock
50,000
$7.3
$364,850
Option
SHULTZ GEORGE Pdirectordirector
Non-Qualified Stock Option (right to buy)
200,000
$4
$800,000
Option
SHULTZ GEORGE Pdirectordirector
Common Stock
208,000
$4.38
$910,000
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
88,400
$4.34
$383,568
Sale
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
55,600
$38.99
$2,167,900
Option
MOORE NICHOLAS Gdirectordirector
Common Stock
30,000
$26.73
$801,900
Sale
MOORE NICHOLAS Gdirectordirector
Common Stock
30,000
$38.69
$1,160,700
Sale
SHULTZ GEORGE Pdirectordirector
Common Stock
208,000
$39.14
$8,141,328
Sale
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Common Stock
57,900
$37.41
$2,165,923
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Common Stock
57,900
$13.77
$797,167
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Non-Qualified Stock Option (Right to Buy)
28,000
$7.08
$198,184
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Incentive Stock Option (right to buy)
200
$37.4
$7,480
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Common Stock
30,000
$11.76
$352,740
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Non-Qualified Stock Option (right to buy)
30,000
$11.76
$352,740
Sale
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Common Stock
30,000
$36.26
$1,087,830
Option
DENNY JAMES Mdirectordirector
Common Stock
20,000
$4
$80,000
Sale
DENNY JAMES Mdirectordirector
Common Stock
15,000
$35.04
$525,570
Option
DENNY JAMES Mdirectordirector
Non-Qualified Stock Option (right to buy)
40,000
$4
$160,000
Sale
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Common Stock
20,000
$35.29
$705,700
Sale
MARTIN JOHN Cdirectordirector
Common Stock
35,000
$34.9
$1,221,640
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Common Stock
20,000
$11.76
$235,160
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Non-Qualified Stock Options (right to buy)
20,000
$11.76
$235,160
Option
MARTIN JOHN Cdirectordirector
Common Stock
35,000
$4.09
$143,290
Option
MARTIN JOHN Cdirectordirector
Non-qualified stock option (right to buy)
35,000
$4.09
$143,290
Sale
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Common Stock
169,496
$33.17
$5,621,504
Option
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Common Stock
166,296
$7.3
$1,213,462
Option
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Non Qualified Stock Option (right to buy)
166,296
$7.3
$1,213,462
Option
MARTIN JOHN Cdirectordirector
Common Stock
85,000
$4.09
$347,990
Sale
MARTIN JOHN Cdirectordirector
Common Stock
85,000
$32.13
$2,731,305
Option
MARTIN JOHN Cdirectordirector
Non-qualified stock option (right to buy)
85,000
$4.09
$347,990
Option
MARTIN JOHN Cdirectordirector
Common Stock
20,000
$3.27
$65,320
Option
MARTIN JOHN Cdirectordirector
Incentive Stock Option (right to buy)
20,000
$3.27
$65,320
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Incentive Stock Option (right to buy)
4,000
$7.3
$29,188
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Common Stock
4,000
$7.3
$29,188
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Incentove Stock Option (right to buy)
30,000
$3.27
$97,980
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
30,000
$3.27
$97,980
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Common Stock
7,600
$3.08
$23,393
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Incentive Stock Option (right to buy)
7,600
$3.08
$23,393
Option
BERG PAULdirectordirector
Non-qualified Stock Option (right to buy)
8,000
$4.78
$38,248
Sale
BERG PAULdirectordirector
Common Stock
8,000
$4.78
$38,248
Option
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Common Stock
32,632
$3.06
$99,952
Option
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Incentive Stock Option (right to buy)
32,632
$3.06
$99,952
Sale
WILSON GAYLE Edirectordirector
Common Stock
104,800
$34.52
$3,617,277
Option
WILSON GAYLE Edirectordirector
Non-Qualified Stock Option (right to buy)
56,800
$20.87
$1,185,473
Option
WILSON GAYLE Edirectordirector
Common Stock
104,800
$24.5
$2,567,810
Option
DENNY JAMES Mdirectordirector
Common Stock
40,000
$4
$160,000
Sale
DENNY JAMES Mdirectordirector
Common Stock
30,000
$36.95
$1,108,500
Showing 2850 to 2900 of 3053 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.